Stryker reported 11 percent increase in net sales for the fourth quarter of 2011, according to a Stryker news release.
Stryker reported preliminary net sales at $2.2 billion for the fourth quarter, driven by a 46.8 percent increase in neurotechnology and spine sales. For the year's end, the company reports preliminary net sales of $8.3 billion, a 13.5 percent increase over the previous year.
During the fourth quarter, the company repurchased 1.8 million shares at a cost of $83 million. In 2011, the company repurchased $622 million in shares.
Related Articles on Orthopedic Devices:
Ortho Kinematics Receives FDA Clearance on KineGraph Vertebral Motion Analyzer
56 Orthopedic & Spine Devices Receive FDA 510(k) Clearance in December
AAOS Releases Technology Overview for Metal-on-Metal Hip Implants
During the fourth quarter, the company repurchased 1.8 million shares at a cost of $83 million. In 2011, the company repurchased $622 million in shares.
Related Articles on Orthopedic Devices:
Ortho Kinematics Receives FDA Clearance on KineGraph Vertebral Motion Analyzer
56 Orthopedic & Spine Devices Receive FDA 510(k) Clearance in December
AAOS Releases Technology Overview for Metal-on-Metal Hip Implants